MSRI
ELV icon

Michael S. Ryan Inc’s Elevance Health ELV Stock Holding History

Michael S. Ryan Inc’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-770
Closed -$400K – 49
2024
Q3 		$400K Hold
770
– – 0.28% 35
2024
Q2 		$417K Sell
770
-20
-3% -$10.6K 0.32% 31
2024
Q1 		$410K Sell
790
-34
-4% -$16.9K 0.32% 33
2023
Q4 		$389K Hold
824
– – 0.32% 34
2023
Q3 		$371K Hold
824
– – 0.35% 31
2023
Q2 		$366K Buy
+824
New +$380K 0.34% 33

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Michael S. Ryan Inc's ELV Position: Q4 2024 in Review

Michael S. Ryan Inc sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 770 shares — an estimated $400K sold.

Michael S. Ryan Inc first reported a position in ELV in Q2 2023 and held it in 6 quarters. The position peaked at $417K in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Michael S. Ryan Inc reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Michael S. Ryan Inc sold 770 Elevance Health shares in Q4 2024, an estimated $400K.
  • Michael S. Ryan Inc first reported a position in Elevance Health in Q2 2023 and held it in 6 quarters.
  • Michael S. Ryan Inc's Elevance Health position peaked at $417K in Q2 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Michael S. Ryan Inc's 13F filing for Q4 2024, filed 8 Jan 2025.